SFDA: Sterile Drugmakers Failing GMP To Stop Production From 2014
This article was originally published in PharmAsia News
Executive Summary
China's State FDA Commissioner Yin Li said authorities will order production halts for sterile drug, vaccine, and blood production lines failing to meet new pharma GMP standards starting in 2014.